| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Glucose and potassium chloride and sodium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing only glucose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Glucose and potassium chloride only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing only glucose and sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing only glucose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing only glucose in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing only glucose and potassium chloride and sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose 400 mg/g oral gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 400 mg/g oral gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 500 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 500 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 400 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 400 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing only glucose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose intake |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose intake |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 75 milligram/1 milliliter and lidocaine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 75 milligram/1 milliliter and lidocaine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing glucose and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing glucose and lidocaine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose and lidocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose 8 g and potassium chloride 300 mg and sodium bicarbonate 300 mg and sodium chloride 200 mg powder for oral solution sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Glucose 8 g and potassium chloride 300 mg and sodium bicarbonate 300 mg and sodium chloride 200 mg powder for oral solution sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Product containing glucose and potassium chloride and sodium bicarbonate and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Glucose and potassium chloride and sodium bicarbonate and sodium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Product containing glucose and potassium chloride and sodium bicarbonate and sodium chloride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Product containing only glucose and potassium chloride and sodium bicarbonate and sodium chloride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Glucose 13.5 g and potassium chloride 1.5 g and sodium chloride 2.6 g and sodium citrate 2.9 g powder for oral solution sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Glucose 13.5 g and potassium chloride 1.5 g and sodium chloride 2.6 g and sodium citrate 2.9 g powder for oral solution sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Product containing glucose and potassium chloride and sodium chloride and sodium citrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Glucose- and potassium chloride- and sodium chloride- and sodium citrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Product containing only glucose and potassium chloride and sodium chloride and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Product containing only glucose and potassium chloride and sodium chloride and sodium citrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Glucose 50 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 50 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 500 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 500 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose 100 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 100 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 100 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 100 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Interstitial fluid glucose concentration (observable entity) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid with sensor placement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose in blood one hour postprandial (observable entity) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose in blood one hour after glucose dose in pregnancy |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing precisely calcium chloride 200 microgram, glucose 50 milligram and potassium chloride 300 microgram and sodium chloride 6 milligram and sodium lactate 3.1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
4 |
| Product containing precisely calcium chloride 200 microgram, glucose 50 milligram and potassium chloride 300 microgram and sodium chloride 6 milligram and sodium lactate 3.1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
4 |
| Product containing calcium chloride and glucose and potassium chloride and sodium chloride and sodium lactate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
4 |
| Product containing only calcium chloride and glucose and potassium chloride and sodium chloride and sodium lactate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
4 |
| Glucose intake |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 250 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose 250 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Blood glucose series (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Fluid sample glucose measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Ward urine dip stick testing for sugar |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Serum random glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Serum fasting glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Serum 2-hr post-prandial glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Plasma random glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Plasma fasting glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Plasma 2-hr post-prandial glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Urine glucose chemical titer measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Random blood glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Fasting blood glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Lunch time blood sugar measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Supper time blood sugar measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Bedtime blood sugar measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Post-prandial blood glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Self-monitoring of blood glucose |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Self-monitoring of urine glucose |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Self-monitoring of blood and urine glucose |
Component |
True |
Glucose |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]